Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
Journal of Experimental & Clinical Cancer Research : CR
|
June 11, 2021
CircPVT1 promotes proliferation of lung squamous cell carcinoma by binding to miR-30d/e
Jie Shi, Xin Lv, Lizhong Zeng, et al.
Journal of Medicinal Chemistry
|
August 11, 2021
Design, Synthesis, and Biological Evaluation of Stable Colchicine-Binding Site Tubulin Inhibitors 6-Aryl-2-benzoyl-pyridines as Potential Anticancer Agents
Hao Chen, Shanshan Deng, Najah Albadari, et al.
Hepatology (Baltimore, Md.)
|
February 25, 2025
β-Catenin regulates distinct pathways from YAP and suppresses ONECUT1 to drive hepatoblastoma development in mice and humans
Weiting Liao, Yi Zhang, Jingxiao Wang, et al.
Molecular Cancer Therapeutics
|
May 2, 2022
Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer
Shanshan Deng, Raisa I Krutilina, Kelli L Hartman, et al.
Cell & Bioscience
|
April 5, 2026
Overexpression of ONECUT1 suppresses hepatoblastoma progression via modulating tumor cell growth and tumor microenvironment
Yu Qiao, Meng Xu, Yanhui Wu, et al.
Frontiers in Cellular and Infection Microbiology
|
July 10, 2023
Analysis of coexisting pathogens in nasopharyngeal swabs from COVID-19
Zhan Gao, Lisong Yu, Ling Cao, et al.
Cancer Letters
|
June 7, 2024
Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer
Damilola Oluwalana, Kelli L Adeleye, Raisa I Krutilina, et al.
Cell Death & Disease
|
June 22, 2024
Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma
Shanshan Deng, Xinjun Lu, Xue Wang, et al.
The Journal of Clinical Investigation
|
April 11, 2023
Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models
Xinjun Lu, Shanshan Deng, Jiejie Xu, et al.
Molecular Cancer Therapeutics
|
September 30, 2025
Repurposing of the Macrolide Antibiotic Clarithromycin for the Prevention of Lung Cancer
Shanshan Deng, Tabish Hussain, Thais F Bartelli, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
Journal of Experimental & Clinical Cancer Research : CR
|
June 11, 2021
CircPVT1 promotes proliferation of lung squamous cell carcinoma by binding to miR-30d/e
Jie Shi, Xin Lv, Lizhong Zeng, et al.
Journal of Medicinal Chemistry
|
August 11, 2021
Design, Synthesis, and Biological Evaluation of Stable Colchicine-Binding Site Tubulin Inhibitors 6-Aryl-2-benzoyl-pyridines as Potential Anticancer Agents
Hao Chen, Shanshan Deng, Najah Albadari, et al.
Hepatology (Baltimore, Md.)
|
February 25, 2025
β-Catenin regulates distinct pathways from YAP and suppresses ONECUT1 to drive hepatoblastoma development in mice and humans
Weiting Liao, Yi Zhang, Jingxiao Wang, et al.
Molecular Cancer Therapeutics
|
May 2, 2022
Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer
Shanshan Deng, Raisa I Krutilina, Kelli L Hartman, et al.
Cell & Bioscience
|
April 5, 2026
Overexpression of ONECUT1 suppresses hepatoblastoma progression via modulating tumor cell growth and tumor microenvironment
Yu Qiao, Meng Xu, Yanhui Wu, et al.
Frontiers in Cellular and Infection Microbiology
|
July 10, 2023
Analysis of coexisting pathogens in nasopharyngeal swabs from COVID-19
Zhan Gao, Lisong Yu, Ling Cao, et al.
Cancer Letters
|
June 7, 2024
Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer
Damilola Oluwalana, Kelli L Adeleye, Raisa I Krutilina, et al.
Cell Death & Disease
|
June 22, 2024
Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma
Shanshan Deng, Xinjun Lu, Xue Wang, et al.
The Journal of Clinical Investigation
|
April 11, 2023
Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models
Xinjun Lu, Shanshan Deng, Jiejie Xu, et al.
Molecular Cancer Therapeutics
|
September 30, 2025
Repurposing of the Macrolide Antibiotic Clarithromycin for the Prevention of Lung Cancer
Shanshan Deng, Tabish Hussain, Thais F Bartelli, et al.
Page
of 12